Literature DB >> 3890754

Chymotrypsin- and trypsin-type serine proteases in rat mast cells: properties and functions.

H Kido, N Fukusen, N Katunuma.   

Abstract

Two of the major enzymes present in and released from rat mast cells are chymotrypsin-type serine protease (chymase) and trypsin-type serine protease (tryptase), and these have been postulated to be important in the inflammatory reactions. There have been no clear data regarding the trypsin-type protease in rat mast cells. Tryptase was recently purified from rat peritoneal mast cells with an associated protein (trypstatin) that inhibited the protease activity above pH 7.5. Chymase was also purified from rat peritoneal cells by employing a one-step method involving hydrophobic chromatography on octyl-Sepharose 4B or arginine-Sepharose 4B. The properties of chymase and tryptase were described in relation to substrate specificity and their relative sensitivity to inhibitors. It was found that proteolytic activities of these enzymes were modulated by naturally occurring substances, such as phosphoglycerides, long-chain fatty acids, and trypstatin. There is as yet little evidence for the physiological roles of these enzymes in the inflammatory reaction. It has been found that the specific, low-molecular-weight inhibitor of chymase, chymostatin, and that of tryptase, leupeptin, inhibit histamine release induced by addition of anti-rat IgE to mast cells. However, the inhibitors with molecular weights of more than 6000 were found to have no effect in this process. The data suggest that chymase and tryptase in mast cell granules play a crucial or significant role in the process of degranulation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3890754     DOI: 10.1016/0003-9861(85)90709-x

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  29 in total

1.  Cloning and characterization of a second complementary DNA for human tryptase.

Authors:  J S Miller; G Moxley; L B Schwartz
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

Review 2.  Roles of mast cell proteases in airways.

Authors:  J A Nadel
Journal:  Drugs       Date:  1989       Impact factor: 9.546

Review 3.  Tryptase and chymase, markers of distinct types of human mast cells.

Authors:  S S Craig; L B Schwartz
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

4.  Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats.

Authors:  Y Araki; A Andoh; Y Fujiyama; T Bamba
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

5.  Mast cell tryptases: examination of unusual characteristics by multiple sequence alignment and molecular modeling.

Authors:  D A Johnson; G J Barton
Journal:  Protein Sci       Date:  1992-03       Impact factor: 6.725

6.  Identification and immunohistochemical localization of various bovine pancreatic trypsin inhibitor-isoforms in bovine pituitary gland.

Authors:  L Fiorucci; G De Renzis; R Businaro; L Fumagalli; E Fioretti; B Giardina; F Ascoli
Journal:  Histochem J       Date:  1989-12

7.  Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice.

Authors:  H Ju; R Gros; X You; S Tsang; M Husain; M Rabinovitch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

8.  Mast cells in human keloid, small intestine, and lung by an immunoperoxidase technique using a murine monoclonal antibody against tryptase.

Authors:  S S Craig; G DeBlois; L B Schwartz
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

9.  Inactivation of thrombin by a complex between rat mast-cell protease 1 and heparin proteoglycan.

Authors:  G Pejler; K Söderström; A Karlström
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

10.  Hyposmotic swelling leads to the expression of trypsin-like activity by rat peritoneal fluid mast cells.

Authors:  C S Vassimon; E T Gomes; A M Rothschild
Journal:  Agents Actions       Date:  1987-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.